Cargando…

Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease

BACKGROUND: The Centiloid scale was developed to standardise the results of beta-amyloid (Aβ) PET. We aimed to determine the Centiloid unit (CL) thresholds for CERAD sparse and moderate-density neuritic plaques, Alzheimer’s disease neuropathologic change (ADNC) score of intermediate or high probabil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amadoru, Sanka, Doré, Vincent, McLean, Catriona A., Hinton, Fairlie, Shepherd, Claire E., Halliday, Glenda M., Leyton, Cristian E., Yates, Paul A., Hodges, John R., Masters, Colin L., Villemagne, Victor L., Rowe, Christopher C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057642/ https://www.ncbi.nlm.nih.gov/pubmed/32131891 http://dx.doi.org/10.1186/s13195-020-00587-5

Ejemplares similares

(18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids
por: Rowe, Christopher C., et al.
Publicado: (2017)

A universal neocortical mask for Centiloid quantification
por: Bourgeat, Pierrick, et al.
Publicado: (2023)

Centiloid scaling for quantification of brain amyloid with [(18)F]flutemetamol using multiple processing methods
por: Battle, Mark R., et al.
Publicado: (2018)

Centiloid method evaluation for amyloid PET of subcortical vascular dementia
por: Yun, Hyuk Jin, et al.
Publicado: (2017)

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
por: Schwarz, Christopher G., et al.
Publicado: (2018)

Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
por: Tan, Rachel H., et al.
Publicado: (2017)

Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET
por: Kim, Soo-Jong, et al.
Publicado: (2022)

The neuropathology of kuru and variant Creutzfeldt–Jakob disease
por: McLean, Catriona A.
Publicado: (2008)

Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
por: Royse, Sarah K., et al.
Publicado: (2021)

β-amyloid in biological samples: not all Aβ detection methods are created equal
por: Adlard, Paul A., et al.
Publicado: (2014)

Appropriate reference region selection of (18)F-florbetaben and (18)F-flutemetamol beta-amyloid PET expressed in Centiloid
por: Cho, Soo Hyun, et al.
Publicado: (2020)

Relationship between amyloid and tau levels and its impact on tau spreading
por: Doré, Vincent, et al.
Publicado: (2021)

Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
por: Su, Yi, et al.
Publicado: (2018)

Operationalizing the centiloid scale for [(18)F]florbetapir PET studies on PET/MRI
por: Coath, William, et al.
Publicado: (2023)

Mesial temporal tau in amyloid-β-negative cognitively normal older persons
por: Krishnadas, Natasha, et al.
Publicado: (2022)

MR-Less Surface-Based Amyloid Assessment Based on (11)C PiB PET
por: Zhou, Luping, et al.
Publicado: (2014)

Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [(18)F] flutemetamol amyloid PET study
por: Hanseeuw, Bernard J., et al.
Publicado: (2020)

Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
por: Burnham, Samantha C, et al.
Publicado: (2020)

Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer’s disease
por: Mukherjee, Soumya, et al.
Publicado: (2021)

Development of software for measuring brain amyloid accumulation using (18)F‐florbetapir PET and calculating global Centiloid scale and regional Z‐score values
por: Matsuda, Hiroshi, et al.
Publicado: (2023)

The use of Centiloids for applying [(11)C]PiB classification cutoffs across region-of-interest delineation methods
por: Tudorascu, Dana L., et al.
Publicado: (2018)

β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020)

Transcriptional Signatures of Tau and Amyloid Neuropathology
por: Castanho, Isabel, et al.
Publicado: (2020)

Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
por: Salvadó, Gemma, et al.
Publicado: (2019)

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
por: Krishnadas, Natasha, et al.
Publicado: (2022)

β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3
por: Bourgeat, Pierrick, et al.
Publicado: (2022)

Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies
por: Fodero-Tavoletti, Michelle T, et al.
Publicado: (2014)

Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness
por: Harrington, Karra D., et al.
Publicado: (2017)

Deep learning from multiple experts improves identification of amyloid neuropathologies
por: Wong, Daniel R., et al.
Publicado: (2022)

Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
por: Gardener, Samantha L., et al.
Publicado: (2021)

Cerebral Microbleeds: A Review of Clinical, Genetic, and Neuroimaging Associations
por: Yates, Paul A., et al.
Publicado: (2014)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

Site of care and factors associated with mortality in unvaccinated Australian aged care residents during COVID‐19 outbreaks
por: Radcliffe, Nicholas J., et al.
Publicado: (2022)

Feasibility evaluation of middle-phase (18)F-florbetaben positron emission tomography imaging using centiloid quantification and visual assessment
por: Wu, Cheng-Han, et al.
Publicado: (2023)

Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events
por: Weekman, Erica M., et al.
Publicado: (2019)

Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition
por: Vacher, Michael, et al.
Publicado: (2019)

Estimation of amyloid distribution by [(18)F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
por: Thal, Dietmar Rudolf, et al.
Publicado: (2018)

Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL (18)F-MK6240 PET study
por: Krishnadas, Natasha, et al.
Publicado: (2023)

Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
por: Wang, Jun, et al.
Publicado: (2011)

Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease
por: Kerbler, Georg M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7ae2s1jq56i1sbtnh4tcaa0o6e